Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
20/08/2026 24:29
BRIEF-Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million Aug 20 (Reuters) - Ascentage Pharma Group International H1 revenue RMB 302.2 million
- H1 net income attributable RMB -816.7 million
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up